首页> 外国专利> Reversible gel for Parenteral drug delivery comprising non-concentric multi-nanodomain vesicles and nanoliposome and Composition for drug delivery comprising the same

Reversible gel for Parenteral drug delivery comprising non-concentric multi-nanodomain vesicles and nanoliposome and Composition for drug delivery comprising the same

机译:包含非同心多纳米域囊泡和纳米脂质体的用于肠胃外药物递送的可逆凝胶和包含所述可逆凝胶的药物递送组合物

摘要

The present invention relates to a non-concentric multi-nanodomain vesicle including two or more liposomes in contact with and connected to each other, and an outer wall surrounding the two or more liposomes; And a nanoliposome, wherein the non-concentric multi-nanodomain vesicle consists of an organic phase containing a hydrophobic drug and an aqueous phase containing a hydrophilic drug and has a negative charge, and the nanoliposome has a positive charge, A reversible gel for parenteral drug delivery is provided. The reversible gel for parenteral drug delivery according to the present invention can increase the encapsulation efficiency of various hydrophobic and hydrophilic drugs, and can be easily injected using a single syringe, and has the property of forming a gel in the body after injection. The present invention overcomes the limitations of the vesicle or liposome-based drug delivery system, which was difficult to induce the sustained-release behavior by moving to the surrounding tissues, and can be used in surgical sites, and loaded with drugs that regulate the functions of cancer cells and various immune cells. When used in combination with an immune checkpoint inhibitor, the reversible gel for parenteral drug delivery according to the above can dramatically improve the efficiency of anticancer immunotherapy.
机译:本发明涉及一种非同心的多纳米域囊泡,该囊泡包括彼此接触并连接的两个或更多个脂质体,以及围绕两个或更多个脂质体的外壁。以及一种纳米脂质体,其中,所述非同心的多纳米域囊泡由含有疏水性药物的有机相和含有亲水性药物的水相构成并且具有负电荷,并且所述纳米脂质体具有正电荷。提供了交付。根据本发明的用于肠胃外给药的可逆凝胶可以提高各种疏水和亲水药物的包封效率,并且可以容易地使用单个注射器注射,并且具有在注射后在体内形成凝胶的性质。本发明克服了基于囊泡或脂质体的药物递送系统的局限性,该局限性难以通过移至周围组织来诱导持续释放行为,并且可以用于手术部位,并装载有调节功能的药物。癌细胞和各种免疫细胞当与免疫检查点抑制剂组合使用时,根据以上所述的用于肠胃外药物递送的可逆凝胶可以显着提高抗癌免疫疗法的效率。

著录项

  • 公开/公告号KR20200095394A

    专利类型

  • 公开/公告日2020-08-10

    原文格式PDF

  • 申请/专利权人 성균관대학교산학협력단;

    申请/专利号KR20200008381

  • 申请日2020-01-22

  • 分类号A61K9/127;A61K31/4745;A61K31/663;A61K31/7068;A61K45/06;A61K9;A61K9/06;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 11:06:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号